138 related articles for article (PubMed ID: 9457836)
41. Perineural invasion is not predictive of biochemical outcome following prostate brachytherapy.
Merrick GS; Butler WM; Galbreath RW; Lief JH; Adamovich E
Cancer J; 2001; 7(5):404-12. PubMed ID: 11693899
[TBL] [Abstract][Full Text] [Related]
42. American Brachytherapy Society survey regarding practice patterns of postoperative irradiation for endometrial cancer: current status of vaginal brachytherapy.
Small W; Erickson B; Kwakwa F
Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1502-7. PubMed ID: 16109462
[TBL] [Abstract][Full Text] [Related]
43. Prostate brachytherapy: treatment strategies.
Stone NN; Stock RG
J Urol; 1999 Aug; 162(2):421-6. PubMed ID: 10411050
[TBL] [Abstract][Full Text] [Related]
44. Patterns of brachytherapy practice for patients with carcinoma of the cervix (1996-1999): a patterns of care study.
Erickson B; Eifel P; Moughan J; Rownd J; Iarocci T; Owen J
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1083-92. PubMed ID: 16099599
[TBL] [Abstract][Full Text] [Related]
45. Interstitial implant alone or in combination with external beam radiation therapy for intermediate-risk prostate cancer: a survey of practice patterns in the United States.
Frank SJ; Grimm PD; Sylvester JE; Merrick GS; Davis BJ; Zietman A; Moran BJ; Beyer DC; Roach M; Clarke DH; Stock RG; Robert Lee W; Michalski JM; Wallner KE; Hurwitz M; Potters L; Kuban DA; Prestidge BR; Vera R; Hathaway S; Blasko JC
Brachytherapy; 2007; 6(1):2-8. PubMed ID: 17284379
[TBL] [Abstract][Full Text] [Related]
46. Timing of computed tomography-based postimplant assessment following permanent transperineal prostate brachytherapy.
Prestidge BR; Bice WS; Kiefer EJ; Prete JJ
Int J Radiat Oncol Biol Phys; 1998 Mar; 40(5):1111-5. PubMed ID: 9539566
[TBL] [Abstract][Full Text] [Related]
47. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838
[TBL] [Abstract][Full Text] [Related]
48. Is supplemental external beam radiation therapy necessary for patients with higher risk prostate cancer treated with 103Pd? Results of two prospective randomized trials.
Merrick GS; Wallner KE; Galbreath RW; Butler WM; Fiano R; Orio PF; Adamovich E
Brachytherapy; 2015; 14(5):677-85. PubMed ID: 26051802
[TBL] [Abstract][Full Text] [Related]
49. Acute urinary toxicity following transperineal prostate brachytherapy using a modified Quimby loading method.
Kang SK; Chou RH; Dodge RK; Clough RW; Kang HL; Bowen MG; Steffey BA; Das SK; Zhou SM; Whitehurst AW; Buckley NJ; Kim JH; Joyner RE; Sarmina I; Montana GS; Ingram SS; Anscher MS
Int J Radiat Oncol Biol Phys; 2001 Jul; 50(4):937-45. PubMed ID: 11429221
[TBL] [Abstract][Full Text] [Related]
50. Five-year biochemical outcome and toxicity with transperineal CT-planned permanent I-125 prostate implantation for patients with localized prostate cancer.
Zelefsky MJ; Hollister T; Raben A; Matthews S; Wallner KE
Int J Radiat Oncol Biol Phys; 2000 Jul; 47(5):1261-6. PubMed ID: 10889379
[TBL] [Abstract][Full Text] [Related]
51. Late rectal function after prostate brachytherapy.
Merrick GS; Butler WM; Wallner KE; Hines AL; Allen Z
Int J Radiat Oncol Biol Phys; 2003 Sep; 57(1):42-8. PubMed ID: 12909214
[TBL] [Abstract][Full Text] [Related]
52. Prostate-specific antigen bounce after prostate seed implantation for localized prostate cancer: descriptions and implications.
Stock RG; Stone NN; Cesaretti JA
Int J Radiat Oncol Biol Phys; 2003 Jun; 56(2):448-53. PubMed ID: 12738319
[TBL] [Abstract][Full Text] [Related]
53. Four-year biochemical outcome after radioimmunoguided transperineal brachytherapy for patients with prostate adenocarcinoma.
Ellis RJ; Vertocnik A; Kim E; Zhou H; Young B; Sodee B; Fu P; Beddar S; Colussi V; Spirnak JP; Dinchman KH; Resnick M; Kinsella TJ
Int J Radiat Oncol Biol Phys; 2003 Oct; 57(2):362-70. PubMed ID: 12957246
[TBL] [Abstract][Full Text] [Related]
54. Effect of cigarette smoking on biochemical outcome after permanent prostate brachytherapy.
Merrick GS; Butler WM; Wallner KE; Galbreath RW; Lief JH; Adamovich E
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1056-62. PubMed ID: 15001245
[TBL] [Abstract][Full Text] [Related]
55. American Brachytherapy Society consensus guidelines for transrectal ultrasound-guided permanent prostate brachytherapy.
Davis BJ; Horwitz EM; Lee WR; Crook JM; Stock RG; Merrick GS; Butler WM; Grimm PD; Stone NN; Potters L; Zietman AL; Zelefsky MJ;
Brachytherapy; 2012; 11(1):6-19. PubMed ID: 22265434
[TBL] [Abstract][Full Text] [Related]
56. Identifying the predictors of acute urinary retention following magnetic-resonance-guided prostate brachytherapy.
Thomas MD; Cormack R; Tempany CM; Kumar S; Manola J; Schneider L; Hurwitz MD; D'Amico AV
Int J Radiat Oncol Biol Phys; 2000 Jul; 47(4):905-8. PubMed ID: 10863058
[TBL] [Abstract][Full Text] [Related]
57. Unification of a common biochemical failure definition for prostate cancer treated with brachytherapy or external beam radiotherapy with or without androgen deprivation.
Fitch DL; McGrath S; Martinez AA; Vicini FA; Kestin LL
Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1430-9. PubMed ID: 16765527
[TBL] [Abstract][Full Text] [Related]
58. Pathologic evidence of dose-response and dose-volume relationships for prostate cancer treated with combined external beam radiotherapy and high-dose-rate brachytherapy.
Kestin LL; Goldstein NS; Vicini FA; Mitchell C; Gustafson GS; Stromberg JS; Chen PY; Martinez AA
Int J Radiat Oncol Biol Phys; 2002 Sep; 54(1):107-18. PubMed ID: 12182980
[TBL] [Abstract][Full Text] [Related]
59. 20 Gy versus 44 Gy supplemental beam radiation with Pd-103 prostate brachytherapy: preliminary biochemical outcomes from a prospective randomized multi-center trial.
Wallner K; Merrick G; True L; Sherertz T; Sutlief S; Cavanagh W; Butler W
Radiother Oncol; 2005 Jun; 75(3):307-10. PubMed ID: 16086912
[TBL] [Abstract][Full Text] [Related]
60. Use of three-dimensional radiation therapy planning tools and intraoperative ultrasound to evaluate high dose rate prostate brachytherapy implants.
Kini VR; Edmundson GK; Vicini FA; Jaffray DA; Gustafson G; Martinez AA
Int J Radiat Oncol Biol Phys; 1999 Feb; 43(3):571-8. PubMed ID: 10078639
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]